Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

In a study of DNAs from 100 breast cancer patients and 100 controls, there were no differences in the frequencies of common or rare alleles at the Harvey ras (c-Ha-ras) locus on chromosome 11. However, one Ha-ras allele was deleted from the tumour DNA in 14 of 65 informative patients. Loss of a Ha-ras allele correlates with paucity of oestrogen receptor protein and with increased tumour size at presentation, but is not associated with microscopic evidence of lymph node invasion. The findings on Ha-ras and other informative loci are consistent with the possibility that a tumour suppressor gene involved in the early stages of breast cancer is located on the short arm of chromosome 11.

[1]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Roberts,et al.  Recognition sequence of specific endonuclease BamHI from Bacillus amyloliquefaciens H , 1977, Nature.

[3]  M. Barbacid,et al.  Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11 , 1982, Nature.

[4]  R. Steele.  Oestrogen receptors and survival in early breast cancer , 1982, British medical journal.

[5]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[6]  D. Moore,et al.  Breast carcinoma etiological factors. , 1983, Advances in cancer research.

[7]  E. Chen,et al.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue , 1983, Nature.

[8]  T. P. Dryja,et al.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.

[9]  D. Larhammar,et al.  Mutations and selection in the generation of class II histocompatibility antigen polymorphism. , 1984, The EMBO journal.

[10]  D. Parkinson,et al.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients , 1985, Nature.

[11]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[12]  N. Copeland,et al.  Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism , 1985, Nature.

[13]  T. Mohandas,et al.  Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high-frequency electrophoretic polymorphism. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Schlom,et al.  Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. , 1986, Cancer research.

[15]  J. Flint,et al.  Ha-ras hypervariable alleles in myelodysplasia , 1986, Nature.

[16]  P. Hasleton,et al.  Genetic predisposition to human lung cancer. , 1986, British Journal of Cancer.

[17]  R. Martuza,et al.  Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma , 1986, Nature.

[18]  R. Nicholson,et al.  Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. , 1986, Cancer research.

[19]  A. Jeffreys,et al.  Characterization of a panel of highly variable minisatellites cloned from human DNA , 1987, Annals of human genetics.

[20]  I. Ellis,et al.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. , 1987, British Journal of Cancer.

[21]  J. Osinga,et al.  Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.

[22]  R. Lidereau,et al.  Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. , 1987, Science.

[23]  W. Cavenee,et al.  Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Mohandas,et al.  Parasexual analysis of human pepsinogen molecular heterogeneity , 1987, Somatic cell and molecular genetics.

[25]  D. Gerhard,et al.  Evidence against Ha-ras-1 involvement in sporadic and familial melanoma , 1987, Nature.

[26]  S. H. Rider,et al.  Chromosome 5 allele loss in human colorectal carcinomas , 1987, Nature.

[27]  A. Viel,et al.  Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. , 1987, British Journal of Cancer.

[28]  R. Weinberg,et al.  Oncogenes and tumor-suppressing genes. , 1988, The New England journal of medicine.

[29]  F. Wyllie,et al.  Ha-ras restriction fragment length polymorphisms in colorectal cancer. , 1988, British Journal of Cancer.

[30]  M. Levene.  Molecular Mechanisms in Familial and Sporadic Cancers , 1988, The Lancet.

[31]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .